TY - JOUR
T1 - Modeling binding modes of α7 nicotinic acetylcholine receptor with ligands
T2 - The roles of Gln117 and other residues of the receptor in agonist binding
AU - Huang, Xiaoqin
AU - Zheng, Fang
AU - Stokes, Clare
AU - Papke, Roger L.
AU - Zhan, Chang Guo
PY - 2008/10/23
Y1 - 2008/10/23
N2 - Extensive molecular docking, molecular dynamics simulations, and binding free energy calculations have been performed to understand how α7-specific agonists of nicotinic acetylcholine receptor (nAChR), including AR-R17779 (1), GTS-21 (4), and 4-OH-GTS-21 (5), interact with the α7 receptor, leading to important new insights into the receptor-agonist binding. In particular, the cationic head of 4 and 5 has favorable hydrogen bonding and cation-π interactions with residue Trp149. The computational results have also led us to better understand the roles of Gln117 and other residues in the receptor binding with agonists. The computational predictions are supported by data obtained from wet experimental tests. The new insights into the binding and structure-activity relationship obtained from this study should be valuable for future rational design of more potent and selective agonists of the α7 receptor.
AB - Extensive molecular docking, molecular dynamics simulations, and binding free energy calculations have been performed to understand how α7-specific agonists of nicotinic acetylcholine receptor (nAChR), including AR-R17779 (1), GTS-21 (4), and 4-OH-GTS-21 (5), interact with the α7 receptor, leading to important new insights into the receptor-agonist binding. In particular, the cationic head of 4 and 5 has favorable hydrogen bonding and cation-π interactions with residue Trp149. The computational results have also led us to better understand the roles of Gln117 and other residues in the receptor binding with agonists. The computational predictions are supported by data obtained from wet experimental tests. The new insights into the binding and structure-activity relationship obtained from this study should be valuable for future rational design of more potent and selective agonists of the α7 receptor.
UR - http://www.scopus.com/inward/record.url?scp=54549103515&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=54549103515&partnerID=8YFLogxK
U2 - 10.1021/jm800607u
DO - 10.1021/jm800607u
M3 - Article
C2 - 18826295
AN - SCOPUS:54549103515
SN - 0022-2623
VL - 51
SP - 6293
EP - 6302
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 20
ER -